PN1114002-02-US Rev A 03/2023
Moving surgery
forward
Results are based on a meta-analyses of 253 peer reviewed literature for robotic-assisted procedures (right
colectomy, LAR/TME, prostatectomy, partial nephrectomy, lobectomy, hysterectomy for endometrial and
cervical cancer) published between 2010-2020. This work was presented at the ISPOR 2021 annual congress.
The summary of clinical results are re† ective of a pooled analysis of 7 systematic literature reviews,
presented by outcome across diˆ erent surgical procedures. While the meta-analysis results provide a
single conclusion that is statistically signiŠ cant or not statistically signiŠ cant, these results are subject to
variability. The results of this analysis may depend on several factors, including but not limited to patient
characteristics, disease characteristics, the procedure of interest, and/or surgeon experience.
Outcomes that favor RAS vs. Lap vs. Open
Length of stay 0.4% days shorter 1.9% days shorter
Conversions 28% less likely
Blood transfusions 22% less likely 70% less likely
30-day complications 14% less likely 39% less likely
30-day mortality 33% less likely 57% less likely
30-day readmissions 23% less likely
Comparable vs. Open
30-day readmissions 6.2% vs. 7.8%
Favors lap/open vs. Lap vs. Open
Operative time 18.8 minutes longer 37.3 minutes longer
Nearly three decades and more than 12 million
procedures performed using da Vinci
®
systems
since inception. Aligning on a shared vision to
consistently deliver better, more predictable
outcomes—that's Intuitive
Recent meta-analysis of key
outcomes across 7 procedures
using da Vinci systems
Important safety information
For important safety information, please refer
to intuitive.com/safety. For a product's intended
use and/or indications for use, risks, full cautions
and warnings, please refer to the associated
User Manual(s).
© 2023 Intuitive Surgical Operations, Inc.
All rights reserved. Product and brand names/logos
are trademarks or registered trademarks
of Intuitive Surgical or their respective holders.
See intuitive.com/trademarks.
